Genetics Generation Advancement Corp.

TPEX:4160 Stock Report

Market Cap: NT$1.3b

Genetics Generation Advancement (4160) Stock Overview

Provides genetic testing and informatics services in Taiwan. More details

4160 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends1/6

Rewards

Price-To-Earnings ratio (27.5x) is below the Biotechs industry average (38.1x)

Earnings grew by 36.4% over the past year

Risk Analysis

High level of non-cash earnings

Dividend of 3.73% is not well covered by earnings or free cash flows

Does not have a meaningful market cap (NT$1B)


4160 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Genetics Generation Advancement Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Genetics Generation Advancement
Historical stock prices
Current Share PriceNT$49.60
52 Week HighNT$150.87
52 Week LowNT$46.90
Beta0.34
1 Month Change-8.15%
3 Month Change-22.74%
1 Year Change-56.76%
3 Year Change132.33%
5 Year Change80.79%
Change since IPO18.00%

Recent News & Updates

Recent updates

Consider This Before Buying Genetics Generation Advancement Corp. (GTSM:4160) For The 2.8% Dividend

Feb 25
Consider This Before Buying Genetics Generation Advancement Corp. (GTSM:4160) For The 2.8% Dividend

Shareholder Returns

4160TW BiotechsTW Market
7D-0.8%2.8%2.4%
1Y-56.8%-17.0%-4.7%

Return vs Industry: 4160 underperformed the TW Biotechs industry which returned -17% over the past year.

Return vs Market: 4160 underperformed the TW Market which returned -4.7% over the past year.

Price Volatility

Is 4160's price volatile compared to industry and market?
4160 volatility
4160 Average Weekly Movement6.4%
Biotechs Industry Average Movement8.4%
Market Average Movement7.4%
10% most volatile stocks in TW Market10.2%
10% least volatile stocks in TW Market4.9%

Stable Share Price: 4160 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4160's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008n/an/awww.gga.asia

Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, and neonatology and pediatrics testing, as well as gastroenterology, hepatology, oncology, and medical research services. It also provides life sciences, materials sciences, research and development management, enterprise quality management, process production operation, and e-submission products.

Genetics Generation Advancement Corp. Fundamentals Summary

How do Genetics Generation Advancement's earnings and revenue compare to its market cap?
4160 fundamental statistics
Market capNT$1.32b
Earnings (TTM)NT$48.13m
Revenue (TTM)NT$638.35m
27.5x
P/E Ratio
2.1x
P/S Ratio

Is 4160 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4160 income statement (TTM)
RevenueNT$638.35m
Cost of RevenueNT$364.30m
Gross ProfitNT$274.05m
Other ExpensesNT$225.92m
EarningsNT$48.13m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)1.80
Gross Margin42.93%
Net Profit Margin7.54%
Debt/Equity Ratio5.3%

How did 4160 perform over the long term?

See historical performance and comparison

Dividends

3.7%
Current Dividend Yield
103%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/01 03:39
End of Day Share Price 2025/07/01 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genetics Generation Advancement Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Regina LeeJih Sun Securities Investment Consulting Co., Ltd.
OSZAR »